Drug safety management software and pharmacovigilance data helps in reviewing, classifying, creating other pharmacovigilance data is termed as PV software (or Pharmacovigilance software). The software also helps in the creation of adverse event reports. The pharmacovigilance and drug safety software market is expected to reach $207.7 Million by 2025 from $143.5 Million in 2017, at a CAGR of 6.5% during the forecast period. Factors such as development of novel and safe drugs and increasing incidence rates of adverse drug reactions are expected to drive the market growth for pharmacovigilance and drug safety software market. Lack of pharmacovigilance professionals and shortage of standard regulations are the factors hampering the market growth. Emerging economies and increasing implementation rate of this drug safety software are becoming the opportunities for pharmacovigilance and drug safety software.
Research Study Objectives:
- Define, estimate, and forecast the Pharmacovigilance and Drug Safety Software market statistics by functionality, delivery mode, end user (Segments), and regions concerning the individual growth drivers, market trends and their contribution toward the Pharmacovigilance and Drug Safety Software market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Pharmacovigilance and Drug Safety Software Market Analysis
- Analysis and conclusions on the future Pharmacovigilance and Drug Safety Software market outlook.
Top-down and bottom-up approaches are used to validate the Pharmacovigilance and Drug Safety Software Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek,
Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Pharmacovigilance and Drug Safety Software Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Pharmacovigilance and Drug Safety Software market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Pharmacovigilance and Drug Safety Software market segmentation is as follows:
By Functionality
- Adverse event reporting software
- Drug safety audits software
- Issue tracking software
- Fully integrated software
By Delivery Mode
- On-Premise delivery mode
- On-Demand/Cloud Based (Saas) Delivery Mode
By End-Users
- Pharma and biotech companies
- Contract research organizations (CROS)
- Business process outsourcing (BPO) Firms
- Other pharmacovigilance service providers
Geographical Analysis:
Pharmacovigilance and drug safety software market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New
Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Pharmacovigilance and Drug Safety Software Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Pharmacovigilance and Drug Safety Software Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Pharmacovigilance and Drug Safety Software market players, such as
- Ab Cube.
- ArisGlobal LLC
- Ennov Solutions, Inc.
- Online Business Applications, Inc.
- Oracle Corporation.
- Along with these companies, many other companies are considered in the report while analysing the Global Pharmacovigilance and Drug Safety Software competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
